These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6185649)

  • 1. Plasma concentrations of valproate during maintenance therapy in epileptic children.
    Lundberg B; Nergårdh A; Boréus LO
    J Neurol; 1982; 228(2):133-41. PubMed ID: 6185649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic and pharmacodynamic interactions of valproate, phenytoin, phenobarbitone and carbamazepine with curcumin in experimental models of epilepsy in rats.
    Reeta KH; Mehla J; Pahuja M; Gupta YK
    Pharmacol Biochem Behav; 2011 Sep; 99(3):399-407. PubMed ID: 21641922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sodium valproate: dose-plasma level relationships and interdose fluctuations.
    Vajda FJ; Mihaly GW; Miles JL; Morris PM; Bladin PF
    Clin Exp Neurol; 1978; 15():145-53. PubMed ID: 386306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum concentrations of valproic acid: influence of dose and comedication.
    May T; Rambeck B
    Ther Drug Monit; 1985; 7(4):387-90. PubMed ID: 3936236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged use of phenytoin, carbamazepine or valproate monotherapy on plasma levels of folate and B(12): a comparison between epileptic patients with or without cardiovascular disorders.
    Otoom S; Bakhiet M; Khan A; Sequeira R
    Neuro Endocrinol Lett; 2006; 27(1-2):85-8. PubMed ID: 16648782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A model for estimating individualized valproate clearance values in children.
    Botha JH; Gray AL; Miller R
    J Clin Pharmacol; 1995 Oct; 35(10):1020-4. PubMed ID: 8568010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valproic acid in childhood epilepsy: anticonvulsive efficacy in relation to its plasma levels.
    Klotz U; Schweizer C
    Int J Clin Pharmacol Ther Toxicol; 1980 Oct; 18(10):461-5. PubMed ID: 6782028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Blood level profile of valproate administration under therapeutic conditions in children].
    Meyer FP; Sauer I; Staemmler U; Walther H
    Padiatr Grenzgeb; 1990; 29(4):325-30. PubMed ID: 2216528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the pharmacokinetics of total and free valproate in mono- and bitherapy with carbamazepine in epileptic children and adolescents.
    Steinborn B; Galas-Zgorzalewicz B
    Folia Neuropathol; 2002; 40(2):97-100. PubMed ID: 12230261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of sodium valproate and phenytoin as single drug treatment in epilepsy.
    Shakir RA; Johnson RH; Lambie DG; Melville ID; Nanda RN
    Epilepsia; 1981 Feb; 22(1):27-33. PubMed ID: 6781888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Valproate monotherapy in children.
    Murphy JV
    Am J Med; 1988 Jan; 84(1A):17-22. PubMed ID: 3146220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic interaction of brivaracetam on carbamazepine in adult patients with epilepsy, with and without valproate co-administration.
    Stockis A; Sargentini-Maier ML; Brodie MJ
    Epilepsy Res; 2016 Dec; 128():163-168. PubMed ID: 27842261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diurnal fluctuations in free and total plasma concentrations of valproic acid at steady state in epileptic patients.
    Riva R; Albani F; Cortelli P; Gobbi G; Perucca E; Baruzzi A
    Ther Drug Monit; 1983 Jun; 5(2):191-6. PubMed ID: 6410545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unnecessary polypharmacy in patients with frequent seizures.
    Callaghan N; O'Dwyer R; Keating J
    Acta Neurol Scand; 1984 Jan; 69(1):15-9. PubMed ID: 6422691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Efficient serum concentrations after single doses of antiepileptic drugs: concept of loading-dose].
    Bittencourt PR; Richens A
    Arq Neuropsiquiatr; 1985 Mar; 43(1):11-6. PubMed ID: 3925929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of therapeutic drug level monitoring of phenobarbital, phenytoin and carbamazepine in Iranian epileptic patients.
    Babaei A; Eslamai MH
    Int J Clin Pharmacol Ther; 2007 Feb; 45(2):121-5. PubMed ID: 17323792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenytoin-valproate interaction: importance of saliva monitoring in epilepsy.
    Knott C; Hamshaw-Thomas A; Reynolds F
    Br Med J (Clin Res Ed); 1982 Jan; 284(6308):13-6. PubMed ID: 6797618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rectal administration of sodium valproate in children.
    Scanabissi E; Dal Pozzo D; Franzoni E; Galloni C; Mengoli G; Calivà R
    Ital J Neurol Sci; 1984 Jun; 5(2):189-93. PubMed ID: 6432726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma sodium valproate levels and clinical response in epilepsy.
    Anthony M; Hinterberger H; Lance JW
    Clin Exp Neurol; 1977; 14():208-15. PubMed ID: 358186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychiatric aspects of epilepsy in childhood treated with carbamazepine, phenytoin or sodium valproate: a random trial.
    Berg I; Butler A; Ellis M; Foster J
    Dev Med Child Neurol; 1993 Feb; 35(2):149-57. PubMed ID: 8444328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.